Tetsuya Yumoto Selected Research

Tetsuya Yumoto Research Topics

Disease

13	Wounds and Injuries (Trauma) 01/2024 - 12/2013
10	Out-of-Hospital Cardiac Arrest 03/2024 - 07/2014
6	Hemorrhage 01/2024 - 10/2015
6	Heart Arrest (Cardiac Arrest) 01/2024 - 01/2017
6	Sepsis (Septicemia) 12/2023 - 12/2014
5	Reperfusion Injury 11/2022 - 07/2016
4	Shock 01/2021 - 07/2014
3	Brain Death (Brain Dead) 01/2024 - 02/2023
3	Septic Shock (Toxic Shock Syndrome) 01/2023 - 12/2014
2	Critical Illness (Critically Ill) 03/2024 - 04/2017
2	Hematoma 09/2023 - 12/2013
2	Deglutition Disorders (Dysphagia) 07/2023 - 01/2022
2	Ventricular Fibrillation 04/2023 - 07/2014
2	Pulmonary Embolism 02/2023 - 01/2016
2	Lung Injury 01/2023 - 04/2019
2	Acute Lung Injury 01/2023 - 04/2019
2	Hyponatremia 01/2023 - 01/2015
2	Neoplasms (Cancer) 01/2022 - 09/2007
2	Hemorrhagic Shock 04/2019 - 12/2013
2	Abdominal Pain (Pain, Abdominal) 01/2019 - 01/2019
2	Bacteremia 04/2017 - 12/2014
2	Venous Thrombosis (Deep-Vein Thrombosis) 01/2016 - 10/2015
1	Frailty 03/2024
1	Atrophy 03/2024
1	Hypoxia (Hypoxemia) 01/2024
1	Hypothyroidism 01/2023
1	Edema (Dropsy) 01/2023
1	Contusions 01/2023
1	Respiratory Acidosis 01/2023
1	Pneumonia (Pneumonitis) 01/2023
1	Anaphylaxis (Anaphylactic Shock) 11/2022
1	Cerebral Hemorrhage 11/2022
1	Mediastinal Emphysema (Pneumomediastinum) 01/2022
1	Osteolysis 01/2022
1	Melanoma (Melanoma, Malignant) 01/2022
1	Burns 12/2020
1	Cysts 12/2019
1	Dermatitis 04/2019
1	Diabetes Mellitus 11/2018
1	Cystitis 11/2018
1	Atrial Heart Septal Defects (Atrial Septal Defect) 04/2018
1	Meningoencephalitis 01/2018
1	Hyperammonemia 01/2018
1	Brain Diseases (Brain Disorder) 01/2018
1	Venous Thromboembolism 10/2017

Drug/Important Bio-Agent (IBA)

4	HydrogenIBA 01/2023 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2022 - 12/2014
2	Lactic Acid (Lactate)FDA LinkGeneric 01/2024 - 01/2023
2	AnticoagulantsIBA 09/2023 - 10/2015
2	AntioxidantsIBA 01/2023 - 07/2016
2	Epinephrine (Adrenaline)FDA LinkGeneric 11/2022 - 01/2020
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 04/2019
2	Oxygen (Dioxygen)IBA 11/2018 - 02/2017
1	Methanol (Carbinol)IBA 01/2024
1	Blood Coagulation Factors (Coagulation Factor)IBA 07/2023
1	Hemoglobins (Hemoglobin)IBA 07/2023
1	salicylhydroxamic acid (SHAM)IBA 01/2023
1	Ethanol (Ethyl Alcohol)IBA 01/2023
1	CreatinineIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Phenobarbital (Luminal)FDA Link 11/2022
1	Biliverdine (Biliverdin)IBA 11/2022
1	Indicators and Reagents (Reagents)IBA 11/2022
1	AmmoniaIBA 05/2022
1	Insulin (Novolin)FDA Link 01/2022
1	Nicotine FDA Link 12/2020
1	Calcium HydroxideIBA 04/2019
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2018
1	fibrin fragment D (D-dimer)IBA 10/2017

Therapy/Procedure

13	Resuscitation 03/2024 - 01/2014
9	Therapeutics 12/2023 - 12/2014
8	Cardiopulmonary Resuscitation (CPR) 01/2024 - 01/2021
3	Critical Care (Surgical Intensive Care) 02/2023 - 07/2014
2	Activities of Daily Living (ADL) 03/2024 - 07/2023
2	Erythrocyte Transfusion 01/2024 - 07/2023
2	Extracorporeal Membrane Oxygenation 01/2024 - 07/2014
2	Punctures 12/2023 - 01/2021
2	Ligation 12/2023 - 01/2021
2	Length of Stay 07/2023 - 01/2016
2	Enteral Nutrition (Feeding, Tube) 07/2023 - 01/2019
2	Airway Management 03/2022 - 01/2016
2	Conservative Treatment 01/2022 - 10/2015
2	Surgical Amputation (Amputations) 03/2021 - 01/2017
2	Hyperbaric Oxygenation 11/2018 - 04/2018
1	Resuscitation Orders (Do Not Resuscitate Orders) 12/2023
1	Extracorporeal Circulation 04/2023
1	Advanced Cardiac Life Support (Life Support, Advanced Cardiac) 04/2023
1	Cesarean Section (Caesarean Section) 02/2023
1	Terminal Care (Care, Terminal) 02/2023
1	Respiratory Therapy (Therapy, Respiratory) 01/2023
1	Precision Medicine 01/2023
1	Language Therapy (Language Training) 01/2022
1	Injections 01/2022
1	Replantation 03/2021
1	Thoracotomy 01/2021
1	Catheters 12/2019
1	MT protocol 12/2019
1	Laparotomy 01/2019
1	Drug Therapy (Chemotherapy) 01/2018